Faro Health provides a cloud platform that lets biopharma and medical-device teams collaboratively design clinical studies, aiming to answer key scientific questions while minimizing burden on patients, sites, payers, and regulators. Its software standardizes and transforms protocol content, using automation to eliminate inconsistencies and errors. The structured content can then be reused to generate study documents and feed downstream systems, creating an end-to-end digital infrastructure for "smart" clinical trials. Customers benefit from faster, more accurate study setup and reduced operational friction. The company plans to use its newly raised capital to accelerate growth and broaden its operational footprint. While specific revenue or user metrics were not disclosed, Faro Health has secured $20 million in institutional backing to fund these initiatives.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2023